AA
Aditya Arun Kumar
About Aditya Arun Kumar
Data last updated:
Aditya Arun Kumar is a Director at Strides Pharma Science Limited (since 2024), Director at Velbiom Probiotics Private Limited (since 2017) and Director at Strides Consumer Private Limited (since 2024), and holds 3 more current directorships. The companies operate in Pharma, Trading and Business Outsourcing. The 4 current companies with reported revenue have a combined latest revenue of ₹5,036 Cr; the largest is Strides Pharma Science Limited at ₹5,009 Cr (FY 2026). Earlier, Aditya Arun Kumar was a Director at Steriscience Specialties Private Limited (2021–2025) and Designated Partner at Karuna Business Solutions Llp (2014–2024) and 5 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Jun 2024 | 1990 | ₹5,009 Cr (FY 2026) | Active | |
| Director | 31 Mar 2017 | 2015 | ₹22.58 Cr (FY 2025) | Active | |
| Director | 30 Aug 2024 | 2017 | ₹3.50 Cr (FY 2025) | Active | |
| Director | 06 Jan 2021 | 2020 | ₹13.2 Lakh (FY 2023) | Under Process Of Striking Off | |
| Non- Individual Subscriber | 15 Sep 2026 | 2026 | Active | ||
| Designated Partner | 08 Sep 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 27 Jan 2021 | 2020 | ₹9.53 Cr (FY 2025) | Active | |
| Designated Partner | 03 Dec 2014 | 2014 | Active | ||
| Director | 04 Jun 2018 | 2007 | ₹101 Cr (FY 2025) | Active | |
| Director | 25 Apr 2023 | 2016 | ₹1,071 Cr (FY 2024) | Active | |
| Director | 25 May 2017 | 2006 | ₹6 Lakh (FY 2022) | Active | |
| Director | 31 Dec 2020 | 2016 | ₹160 Cr (FY 2021) | Amalgamated | |
| Director | 13 Aug 2018 | 2017 | ₹20.8 Lakh (FY 2022) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Aditya Arun Kumar
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aditya Arun Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aditya Arun Kumar
Aditya Arun Kumar currently holds 6 directorships: Strides Pharma Science Limited (Director, since 01 Jun 2024, revenue ₹5,009 Cr (FY 2026)); Velbiom Probiotics Private Limited (Director, since 31 Mar 2017, revenue ₹22.58 Cr (FY 2025)); Strides Consumer Private Limited (Director, since 30 Aug 2024, revenue ₹3.50 Cr (FY 2025)); Steribrooks Penems Private Limited (Director, since 06 Jan 2021, revenue ₹13.2 Lakh (FY 2023)); Pharma Platforms Private Limited (Non- Individual Subscriber, since 15 Sep 2026); and 1 more.
Aditya Arun Kumar was first appointed on 03 Dec 2014 as Designated Partner at Karuna Business Solutions Llp. The most recent appointment on record is 15 Sep 2026 at Pharma Platforms Private Limited.
The 4 current companies of Aditya Arun Kumar that report revenue have a combined latest revenue of ₹5,036 Cr: Strides Pharma Science Limited ₹5,009 Cr (FY 2026); Velbiom Probiotics Private Limited ₹22.58 Cr (FY 2025); Strides Consumer Private Limited ₹3.50 Cr (FY 2025); Steribrooks Penems Private Limited ₹13.2 Lakh (FY 2023).
Aditya Arun Kumar held 7 earlier board appointments: Steriscience Specialties Private Limited (Director, 27 Jan 2021 to 31 Jul 2025); Karuna Business Solutions Llp (Designated Partner, 03 Dec 2014 to 14 Oct 2024); Instapill Private Limited (Director, 04 Jun 2018 to 19 Aug 2024); Tenshi Pharmaceuticals Private Limited (Director, 25 Apr 2023 to 06 Oct 2023); Triphase Pharmaceuticals Private Limited (Director, 25 May 2017 to 02 Mar 2023); and 2 more.
The current boards of Aditya Arun Kumar's companies include Ameet Pratapsinh Hariani (Strides Pharma Science Limited), Arun Kumar Pillai (Strides Pharma Science Limited), Badree Komandur (Strides Pharma Science Limited), Badree Komandur (Strides Pharma Science Limited), Homi Rustam Khusrokhan (Strides Pharma Science Limited), Kausalya Santhanam (Strides Pharma Science Limited), among others.